Brief: Pure Biologics Signs Deal For Running Pre-Clinical Trial In PB004 Project
28/03/2022 07:29
March 28 (Reuters) - Pure Biologics SA PUR1.WA :
* SIGNS DEAL WITH THE JACKSON LABORATORY TO RUN PRE-CLINICAL
TRIAL
IN PB004 PROJECT
* PB004 RELATES TO THERAPEUTIC TREATMENT OF SOLID TUMORS AND
LEUKEMIA
Source text for Eikon: ID:nEM3kx54ra
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects